Comparison of severe healthcare-associated pneumonia with severe community-acquired pneumonia

Lung. 2014 Apr;192(2):313-20. doi: 10.1007/s00408-013-9541-x. Epub 2013 Dec 1.

Abstract

Background: We compared the demographic characteristics and outcomes of patients with severe healthcare-associated pneumonia (HCAP) to those with severe community-acquired pneumonia (CAP).

Methods: This was a retrospective study of prospectively collected data from all consecutive patients with severe pneumonia who were admitted to the hospital through the emergency department between January 2008 and December 2010.

Results: During the study period, 247 patients had severe pneumonia; of these, 107 had severe CAP and 140 had severe HCAP. There was no significant difference in demographic characteristics between the two groups, except for comorbidities. Although the incidence of potentially drug-resistant pathogens was higher in patients with severe HCAP than in those with severe CAP (34 vs. 6 %, P = 0.004), there was no statistically significant difference in the rate of inappropriate antibiotic treatment (16 vs. 3 %, P = 0.143). Finally, clinical outcomes, such as intensive care unit admission, length of hospital stay, and in-hospital mortality, were not different between the two groups. In a multiple logistic regression analysis, a higher PSI score (adjusted OR 1.01; 95 % CI 1.00-1.02; P = 0.024) and the need for mechanical ventilation (adjusted OR 2.62; 95 % CI 1.37-5.00; P = 0.004) were independently associated with in-hospital mortality. However, the type of pneumonia was not associated with in-hospital mortality after adjusting for potential confounding factors.

Conclusions: The severity of illness rather than the type of pneumonia might be associated with in-hospital mortality in patients with severe pneumonia.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Chi-Square Distribution
  • Community-Acquired Infections* / diagnosis
  • Community-Acquired Infections* / drug therapy
  • Community-Acquired Infections* / microbiology
  • Community-Acquired Infections* / mortality
  • Comorbidity
  • Cross Infection* / diagnosis
  • Cross Infection* / drug therapy
  • Cross Infection* / microbiology
  • Cross Infection* / mortality
  • Drug Resistance, Bacterial
  • Female
  • Hospital Mortality
  • Humans
  • Incidence
  • Length of Stay
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Pneumonia, Bacterial* / diagnosis
  • Pneumonia, Bacterial* / drug therapy
  • Pneumonia, Bacterial* / microbiology
  • Pneumonia, Bacterial* / mortality
  • Republic of Korea / epidemiology
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents